medigraphic.com
Revista Cubana de Anestesiología y Reanimación

2016, Number 2

Revista Cubana de Anestesiología y Reanimación 2016; 15 (2)

Pharmacological cardioprotection in cardiovascular anesthesia. Diltiazem vs nitroglycerin

Guzmán BJD, Cruz BR, Cabrera PAJ, Suarez LJM

Language: Spanish
References: 25
Page: 97-114
PDF size: 404.04 Kb.


ABSTRACT

Introduction: in the cases of ischemic cardiopathy patients, different preventive strategies have been designed to limit the damage for ischemia-reperfusion, in order to optimize the balance in myocardial oxygen consumption.
Objectives: To determine what cardio-protective (nitroglycerin or diltiazem) strategy is more effective in coronary revascularization.
Methods: A randomized therapeutic trial was conducted to assess the cardioprotective effect of diltiazem and nitroglycerin in patients intervened with heart beating.
Results: 175 patients were studied: the nitroglycerin group N=90 patients and the diltiazem group D=85. Sustained myocardial ischemia in group D was 20% vs. 12% in N; p=0.04. ST infra-imbalance prevailed. It was 10% in the N group vs 39% in group D; p = 0.002. The most frequent alteration was segmental hypokinesia in 36% of the patients. Akinesia was higher in group D, 9.4% vs. group N 4.4%; p = 0.05. The average value of mean intraoperative blood pressure was 80 mm/Hg in the group N vs.61.4 mm/Hg in group D; p = 0.003. The average heart rate in the group N was 63 bpm vs Group D which was 50 bpm; p = 0.006. The most common arrhythmia was atrial fibrillation 28%, in the N group 34% vs. group D 21%, p = 0.037. The average value of troponin after 24 h was 125 pg/ml in group D vs.97.7 pg/ml in group N; p = 0.042. Adverse effects were minimal. Sustained hypotension in group D was 30% vs 5.5% in group N; p = 0.002. AV block was observed in the group N 4% vs 15% in group D; p = 0.01. Perioperative IMA was 2.2 times more frequent with diltiazem than with nitroglycerin.
Conclusions: Perioperative infusion of nitroglycerin provides better cardioprotective effect then diltiazem in preventing sustained ischemic events, associated with less release of T troponin and better hemodynamic stability. Diltiazem is associated with a decreased risk of postoperative atrial fibrillation. Adverse effects and complications prevailed in patients treated with diltiazem. IMA perioperative risk was 2.2 times higher in this group.


REFERENCES

  1. Ferreira González I. Epidemiología de la enfermedad coronaria. Rev Esp Cardiol. 2014. [Internet]. 2010 [Citado el 30 de noviembre de 2014]; Disponible en: http://dx.doi.org/10.1016/j.recesp.2013.10.003/

  2. Agüero MO, Cruz BR, Cabrera PA, Suárez LJ, Pérez M. Procedimiento quirúrgico de revascularización miocárdica sin circulación extra- corpórea: Antecedentes. Cuidados anestésicos. Rev Cub Anest Reanim. 2008; 7(2).Internet. [Citado el 14 de diciembre de 2012] Disponible en: http://bvs.sld.cu/revistas/scar/indice.htm/

  3. Buchanan GL. "Elección de intervención coronaria percutánea o bypass en la enfermedad coronaria multivaso". Rev Esp Cardiol. 2013. Internet. [Citado el 21 de septiembre de 2014] Disponible en: http://dx.doi.org/10.1016/j.recep.2013.08.017/

  4. Braunwald E, Zipes DP, Lobby P. Tratamiento médico del paciente sometido a Cirugía Cardiaca. Tratado de Cardiología, 6ta ed. Londres. 2006. Pp. 2538-69.

  5. Rodríguez K, Herrera M, Machin J. Circulación extracorpórea en Cirugía Cardiovascular: en Guevara LA. Cirugía Cardiovascular.1ra ed. La Habana. 2009. p. 53-93.

  6. Cabrera AJ, Cruz BR, Suárez J. Anestesia en Cirugía Cardiaca: En Guevara LA: Cirugía Cardiovascular. 1ra ed. La Habana. 2009; 2:20-52.

  7. Bueno Gonzales AM, Pérez Vela JM, et al. Diagnóstico y Alternativas terapéuticas en la isquemia miocárdica aguda perioperatoria en Cirugía Coronaria. Med Intensiva. 2010;34(1):64-73.

  8. Peix GA. Isquemia miocárdica aguda y enfermedad coronaria microvascular.Rev Cub Cardiol Cir Cardiovasc. 2010;16(3):264-75.

  9. García-Dorado D. Protección contra el daño miocárdico por Isquemia- reperfusión en la práctica clínica. Rev Esp Cardiol. 2014. Internet. [Citado el 4 de diciembre de 2014]. Disponible en: http://dx.doi.org/10.1016/j.recesp.2014.01.011

  10. Shanewise JS. Off- pump coronary surgery: How do the Anesthetic considerations differ? Anesthesiology Clin N Am. 2008;21:613-23.

  11. Takeo Sl. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/ reperfusion injury. Biochem Pharmacol 2010;67(3):565-74.

  12. Zhang P, Chen G. Cardioprotective effects of diltiazem infusion in the perioperative period in patients undergoing CABG. Eur J Cardiothorac Surg. 2008;25(4):553-59.

  13. Thygesen K, Alpert JS, Jaffe AS, Simons ML. Tercera definición universal de infarto del miocardio. Documento de consenso de expertos: ESC / ACCF / AHA / WHF. Rev Esp Cardiol. 2013;66 (2):132. e1-e15. Internet. [Citado el 18 de febrero de 2014]. Disponible en: http://dx.doi,org/10.1016/j.jac.2012.08.001/

  14. González-Chon O. Insuficiencia cardíaca y anestesia. Rev Mex Anest. 2012;35 (1):300-05. Internet. [Citado el 10 de septiembre de 2013] Disponible en: http://www.medigraphic.com/rma

  15. Wijns W, et al. Guía de práctica clínica sobre revascularización miocárdica Rev Esp Cardiol. 2010; 63(12):1485.e1-e76. Internet. [Citado el 10 de diciembre de 2013] Disponible en: http://www.revespcardiol.org

  16. Hamm CW. Guía de práctica clínica de la ESC para el manejo del Síndrome coronario agudo. Rev Esp Cardiol. 2012; 65(2):173.e1-e55. Internet. [Citado el 8 de julio de 2014] Disponible en: http://www.revespcardiol.org/guidelines

  17. Tabel Y, Erdal C. Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery".Eur J Cardiothorac Surg. 2009;25(4):553-59.

  18. Zhang P, Chen G. Cardio-protective effects of diltiazem infusion In the peri-operative period in patients undergoing CABG. Eur J Cardiothorac Surg. 2008; 25(4):553-59.

  19. Oz M. Shapira, M, Joseph D. Alkon J. Nitroglycerin Is Preferable to Diltiazem for prevention of Coronary Bypass Conduit Spasm. Ann Thorac Surg. 2010;70:883-9

  20. Weng ZC, Lin CY, Loh SH, et al. Coronary arteryspasm after off-pump coronary artery bypass grafting. Br J Surgery. 2007;77:126-9.

  21. Lezcano A. Fibrilación auricular en el posoperatorio de cirugía Cardiovascular. Rev Conarec. 2008;97(1):411-14.

  22. Duminda N. Wijeysundera D. Calcium Antagonists Reduce Cardiovascular Complications After Cardiac Surgery J Am Coll Cardiol. 2013;41:1496-505.

  23. Cabrera MS, Maribio A."Utilidad del ETE en el diagnóstico de Isquemia Miocárdica Intraoperatoria". Rev Chilena Anestes. 2005;34(2):16-25.

  24. Robertson RM, Robertson D. "Fármacos usados en el tratamiento de la Isquemia miocárdica". En: Goodman LS, Gilman A. Bases farmacológicas de la terapéutica. 9na ed. Monterrey, NL. 2006. p. 813-35.

  25. Bice JS, Keim Y, Stasch JP. "NO-independent stimulation or Activation of soluble guanylylcyclase during early reperfusion limits infarct size".Cardio Vasc Res. 2014;101:220-8.




2020     |     www.medigraphic.com